Related Experiment Video
Updated: Nov 17, 2025
07:32
In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
Published on: September 25, 2021
3.5K
Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
Kevin Verhoeff1, Sarah J Henschke2, Braulio A Marfil-Garza1
1Department of Surgery, University of Alberta, Edmonton, AB T6G 2B7, Canada.
Cells
|February 12, 2021
Summary
Stem cell therapy offers a promising future for diabetes treatment, potentially overcoming limitations of current insulin therapies and islet cell transplantation. Research focuses on generating autologous cells to address immune rejection and donor scarcity for a potential cure.
Area of Science:
- Endocrinology and Metabolism
- Regenerative Medicine
- Stem Cell Biology
Background:
- Current diabetes management with insulin and advanced devices has limitations in achieving physiologic euglycemia.
- Islet cell transplantation is effective for some but faces challenges with donor organ availability and immunosuppression.
- Existing treatments for diabetes mellitus incur significant healthcare costs and patient morbidity/mortality.
Purpose of the Study:
- To review current diabetes treatment modalities, including insulin delivery systems and islet cell transplantation.
- To explore the potential of stem cell-derived islet cells as a cell-based therapy for diabetes.
- To identify barriers to widespread stem cell therapy for diabetes and highlight areas for future research.
Main Methods:
- Review of existing literature on diabetes treatment, islet cell physiology, and stem cell-based therapies.
- Analysis of the limitations of current subcutaneous insulin delivery and artificial pancreas systems.
- Discussion of stem cell generation techniques, including autologous and immune-protected approaches.
Main Results:
- Novel insulin formulations and advanced glucose monitoring/delivery systems offer improvements but do not fully resolve glycemic control.
- Islet cell transplantation shows success but is constrained by donor supply and the need for lifelong immunosuppression.
- Stem cell-derived islet cells present a viable strategy to overcome donor limitations and immune rejection, offering a potential cure.
Conclusions:
- Stem cell therapy, particularly using autologous or immune-protected induced pluripotent stem cells, holds significant promise for treating diabetes.
- Addressing challenges in stem cell generation, immune protection, and clinical translation is crucial for widespread adoption.
- Further research is needed to bridge the gap between current stem cell technology and a widely accessible cure for diabetes.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
25.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
25.3K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
01:21EPS and iPS Cells in Disease Research
3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
01:17Stem Cell Culture
5.8K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.8K
01:23Tissue Renewal without Stem Cells
2.0K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
2.0K